AACR Annual Report 2020

REVENUE AND EXPENSES 2020

2020 was a challenging year for the AACR due to the global pandemic and the resulting economic uncertainty. The impact of COVID-19 on AACR programs and services resulted in declines in both operating revenues and expenses. Due to responsible financial oversight and prudent risk management strategies, the AACR is projected to generate a surplus for the year. Strong returns from the organization’s investments coupled with additional income from non-recurring activities related to meeting event cancellation insurance contributed to this projected surplus.

As a result of the financial performance for the year 2020, the AACR’s unrestricted net assets are now $117 million. The positive financial results allow the AACR to continue strategic investments in its mission-driven activities to prevent and cure all cancers.

2020 TOTAL EXPENSES


2020 PROGRAM EXPENSES


American Association for Cancer Research, Inc. and the AACR Foundation

Unrestricted Revenues and Expenses (Unaudited)
As of December 31, 2020

2019 2020 2020 Percent of Total
REVENUE
Membership Dues $4,468,939 $4,208,025 5%
Publications $19,250,027 $19,089,129 22%
Scientific Meetings and Educational Workshops $27,268,248 $3,178,862 4%
Other Revenue $5,409,856 $9,812,709 11%
Subtotal Program Revenue $56,397,070 $36,288,725 42%
Support
NIH Grants $1,014,481 $115,500 0%
Contributions $67,994,711 $50,859,941 58%
Subtotal Support Revenue $69,009,192 $50,975,441 58%
TOTAL REVENUE $125,406,262 $87,264,166 100%
EXPENSES
Research Grants and Scientific Awards $59,736,868 $45,132,817 46%
Scientific Meetings and Educational Workshops $21,056,320 $11,503,963 12%
Scientific Publications $12,751,100 $12,850,826 13%
Communications, Science Policy, and Patient Education $8,723,784 $7,280,130 7%
Professional Education and Scientific Programs $7,539,398 $11,125,064 11%
Subtotal Program Services $109,807,470 $87,892,800 89%
Member Services and Support Services $8,454,537 $6,550,552 7%
Fundraising and Development $4,212,569 $4,354,087 4%
Subtotal Supporting Services $12,667,106 $10,904,639 11%
TOTAL EXPENSES $122,474,576 $98,797,439 100%
Operating Surplus before Investments $2,931,686 ($11,533,273)
Other Changes
Investment Income/(loss) $16,149,737 $21,425,826
Nonrecurring Items $0 $16,467,291
Subtotal Other Changes $16,149,737 $37,893,117
Change in Unrestricted Net Assets $19,081,423 $26,359,844
NET ASSETS BEGINNING OF YEAR $71,956,328 $91,037,751
NET ASSETS END OF YEAR $91,037,751 $117,397,595